Health Products

APO-Fluoxetine Product Recall (2015-08-25)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
KZ8596B. APO-Fluoxetine 20 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
CapsuleDIN 02216361Fluoxetine (Fluoxetine hydrochloride) 20 mg
MC5453A. APO-Fluoxetine 10 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
CapsuleDIN 02216353Fluoxetine (Fluoxetine hydrochloride) 10 mg

Introduction

Affected Products
  1. APO-Fluoxetine 10 mg
  2. APO-Fluoxetine 20 mg

Reason

The active pharmaceutical ingredient (API) used in the manufacturing of these lots may not meet the specification for impurity- isobutyl vinyl ketone (IBVK)

Depth of distribution

Retailers

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime